NIBIT-MESO-1: limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study

J Thorac Dis. 2018 Nov;10(Suppl 33):S3878-S3881. doi: 10.21037/jtd.2018.09.135.

Authors

Paolo Bironzo¹, Riccardo Taulli²

Affiliations

¹ Thoracic Unit and Medical Oncology Division, Department of Oncology at San Luigi Hospital, University of Torino, Orbassano, Italy.
² Department of Oncology, University of Torino, Torino, Italy.

No abstract available

Publication types

Editorial
Comment